An Evaluation of Overall Survival Between B-cell Maturation Antigen Chimeric Antigen Receptor T cell Therapies and Bispecific Antibodies for the Treatment of Relapsed/Refractory Multiple Myeloma
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03535-9